SEC Filings | Structure Therapeutics

Filing date	Form	Description	View
Nov 17, 2023	10-Q/A	Amendment to a previously filed 10-Q	View HTML 0001558370-23-019202.pdf 0001558370-23-019202.rtf 0001558370-23-019202.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
Nov 17, 2023	10-Q	Quarterly report which provides a continuing view of a company's financial position	View HTML 0001558370-23-019203.pdf 0001558370-23-019203.rtf 0001558370-23-019203.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
Nov 17, 2023	S-1	Registration statement for face-amount certificate companies	View HTML 0001104659-23-119620.pdf 0001104659-23-119620.rtf 0001104659-23-119620.xls
Nov 16, 2023	10-Q/A	Amendment to a previously filed 10-Q	View HTML 0001558370-23-019165.pdf 0001558370-23-019165.rtf 0001558370-23-019165.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
Nov 14, 2023	NT 10-Q	Notification that form type 10-Q will be submitted late	View HTML 0001104659-23-118246.pdf 0001104659-23-118246.rtf 0001104659-23-118246.xls
Nov 14, 2023	8-K	Report of unscheduled material events or corporate event	View HTML 0001104659-23-118241.pdf 0001104659-23-118241.rtf 0001104659-23-118241.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
Oct 23, 2023	4	Statement of changes in beneficial ownership of securities	View HTML 0001209191-23-053321.pdf 0001209191-23-053321.rtf 0001209191-23-053321.xls
Oct 13, 2023	SC 13G/A	An amendment to the SC 13G filing	View HTML 0000315066-23-002705.pdf 0000315066-23-002705.rtf
Oct 12, 2023	3	Initial filing by director officer or owner of more than ten percent	View HTML 0001209191-23-052664.pdf 0001209191-23-052664.rtf 0001209191-23-052664.xls
Oct 04, 2023	SC 13G/A	An amendment to the SC 13G filing	View HTML 0000315066-23-002593.pdf 0000315066-23-002593.rtf

Data provided by Kaleidoscope.